BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of BLI1100 formulations to
placebo for the treatment of moderate to severe acne vulgaris.